TheraBiol, Inc. logo

TheraBiol, Inc.

TheraBiol Inc (TBI) is a biopharmaceutical company founded in May 2012 by a core group of scientists, physicians and entrepreneurs with the support of the QB3 Incubator Program (www.qb3.org) at UCSF. The principal objective at TheraBiol is to develop safe and effective antibodies for the prevention, treatment, and cure of human immunodeficiency virus 1 (HIV-1) infection.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.therabiol.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
185 Berry Street (Lobby 6), CA 94107
San Francisco
United States
Email
Contact Number
+1 415-600-1693

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/therabiol-inc.” connections=”true” suffix=””]